Publications citing Assaypro: Human Apolipoprotein C-I (Apo C1) ELISA Kit... (14 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer’s disease
Examination of external and internal factors for the pathophysiology of pediatric idiopathic steroid-sensitive nephrotic syndrome
Protective effect of inulin and the integrity of the microvasculature in diabetes mellitus
Apolipoprotein C-I Levels Are Associated with the Urinary Protein/Urinary Creatinine Ratio in Pediatric Idiopathic Steroid-Sensitive Nephrotic Syndrome: A Case Control Study
Apolipoprotein C-I Levels Are Associated with the Urinary Protein/Urinary Creatinine Ratio in Pediatric Idiopathic Steroid-Sensitive Nephrotic Syndrome: A Case Control Study
Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping
Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway
Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway
Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping
A Pro-Atherogenic HDL Profile in Coronary Heart Disease Patients: An iTRAQ Labelling-Based Proteomic Approach
MALDI-Based Serum Peptide Signature Discriminating Stomach and Pancreas Adenocarcinoma Patients from Cancer-Free Controls: Adjustment to Diagnosis with Immuno-Based Assays
Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays
The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis
Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis